201 related articles for article (PubMed ID: 19268635)
1. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Butterworth JR
Dig Liver Dis; 2009 May; 41(5):338-9. PubMed ID: 19268635
[No Abstract] [Full Text] [Related]
2. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
Giannini EG; Kane SV; Testa R; Savarino V
Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid.
Kim YH; Kim MH; Kim BJ; Kim JJ; Chang DK; Son HJ; Rhee PL; Rhee JC
Dig Liver Dis; 2009 May; 41(5):328-37. PubMed ID: 18976971
[TBL] [Abstract][Full Text] [Related]
4. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
5. [Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases].
Ioffe AIu
Lik Sprava; 2005 Jun; (4):45-8. PubMed ID: 16158715
[TBL] [Abstract][Full Text] [Related]
6. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Vetter C
MMW Fortschr Med; 2005 Mar; 147(13):10. PubMed ID: 15832752
[No Abstract] [Full Text] [Related]
7. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Subramanian V; Logan RF
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
[TBL] [Abstract][Full Text] [Related]
8. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
10. Estimating the economic burden of inflammatory bowel disease in Canada: physician office visits and mesalamine prescriptions dispensed as surrogate markers.
Wong VK; Lee TK; Yoshida EM
Am J Gastroenterol; 2007 Nov; 102(11):2602-3; author reply 2603-4. PubMed ID: 17958766
[No Abstract] [Full Text] [Related]
11. [5-aminosalicylic acid and cancer prophylaxis?].
Thomsen OO
Ugeskr Laeger; 2006 May; 168(21):2047. PubMed ID: 16768920
[No Abstract] [Full Text] [Related]
12. Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.
OʼConnor A; Packey CD; Akbari M; Moss AC
Inflamm Bowel Dis; 2015 Nov; 21(11):2562-9. PubMed ID: 26296062
[TBL] [Abstract][Full Text] [Related]
13. Review article: the chemoprevention of colorectal carcinoma.
Gasche C
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
[TBL] [Abstract][Full Text] [Related]
14. [Diet and nonsteroidal anti-inflammatory drugs: role in prevention of colorectal cancer].
Herbert C
Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S202-17. PubMed ID: 9762257
[No Abstract] [Full Text] [Related]
15. Chemoprevention of colorectal cancer.
Raju R; Cruz-Correa M
Dis Colon Rectum; 2006 Jan; 49(1):113-24; discussion 124-5. PubMed ID: 16362805
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology and natural history of chronic inflammatory bowel disease].
Lerebours E; Savoye G; Guedon C
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S76-80. PubMed ID: 12704299
[No Abstract] [Full Text] [Related]
17. Mesalazine. Now authorised for children, but no suitable form.
Prescrire Int; 2011 Sep; 20(119):208. PubMed ID: 21954515
[No Abstract] [Full Text] [Related]
18. Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?
Asanuma M; Miyazaki I
Exp Neurol; 2007 Aug; 206(2):172-8. PubMed ID: 17599833
[No Abstract] [Full Text] [Related]
19. Total magnesium intake and colorectal cancer incidence in women.
Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Zhang SM
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2006-9. PubMed ID: 17035414
[No Abstract] [Full Text] [Related]
20. [Non-steroidal anti-inflammatory agents and prevention of colorectal cancer and other types of cancer].
Sørensen HT; Nørgård B; Friis S; Laurberg S; Olsen JH; Kronberg O
Ugeskr Laeger; 2003 Mar; 165(12):1260-1. PubMed ID: 12701310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
